Substituted thienoimidazoles, method for production and use thereof as medicament or diagnostic and medicaments comprising the same

Details for Australian Patent Application No. 2004272225 (hide)

Owner Aventis Pharma Deutschland GmbH

Inventors Heinelt, Uwe; Licher, Thomas; Lang, Hans-Jochen; Wirth, Klaus

Agent Watermark

Pub. Number AU-A-2004272225

PCT Pub. Number WO2005/026173

Priority 103 41 240.9 08.09.03 DE

Filing date 3 September 2004

Wipo publication date 24 March 2005

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/4188 (2006.01)

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

23 March 2006 PCT application entered the National Phase

  PCT publication WO2005/026173 Priority application(s): WO2005/026173

19 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004272246-Lawsonia intracellularis subunit vaccine

2004272210-Removable module for a portable electronic device having stand-alone and system functionality